4D Molecular Therapeutics Chief Legal Officer Scott Bizily disposes of 584 common shares for $8,176

PUBT · 2d ago
4D Molecular Therapeutics Chief Legal Officer Scott Bizily disposes of 584 common shares for $8,176
  • 4D Molecular Therapeutics Chief Legal Officer Scott Bizily exercised stock options for 584 shares at $6.49 on Sept. 1, 2026.
  • Bizily sold 584 shares at $14 on the same day.
  • Directly held common stock fell to 8,617 shares following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 4D Molecular Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-382245), on September 03, 2026, and is solely responsible for the information contained therein.